Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Cornelia G Palivan

Cornelia G Palivan

University of Basel, Switzerland

Title: Artificial organelles: How nanoscience provides therapeutic solutions

Biography

Biography: Cornelia G Palivan

Abstract

Because organelles are key components in cells and comprise compartments loaded with molecules essential to life, their inadequate functioning can contribute to numerous pathological conditions. Creating artificial organelles that aid their natural counterparts in cells will have a dramatic impact on medicine in the treatment of disorders and in the design of artificial cells. To design artificial organelles, nanoscience provides a necessary tool, the self-assembly of amphiphilic copolymers into supramolecular structures such as micelles, tubes, and vesicles. They represent ideal candidates to form organelle-like compartments that can contain combinations of biomolecules. Here, we show the necessary steps for the development of an artificial organelle able to act in situ inside cells. The artificial organelle is based on two enzymes in tandem encapsulated in polymer vesicles with membrane rendered permeable by inserted channel proteins. Polymer vesicles play a dual role: they protect the enzymes from proteolytic attack and allow them to act inside their cavity. An example of the first artificial peroxisome is presented as model for nanosciance based strategy to design artificial organelles. Uptake, absence of toxicity, and in situ activity in cells exposed to oxidative stress demonstrated that the artificial peroxisomes detoxify superoxide radicals and H2O2 after endosomal escape. Our artificial peroxisome combats oxidative stress in cells, a factor in various pathologies (e.g. arthritis, Parkinson’s, cancer, AIDS), and offers a versatile strategy to develop other “cell implants” for cell dysfunction.